Amgen stock price near $342: AMGN heads into earnings after Kyowa Kirin deal exit

Amgen shares slipped roughly 0.3% to close at $341.88 on Friday, a small shift ahead of a hectic week for the stock following its decision to exit an eczema drug partnership. A recent filing revealed that Amgen will pull out of its collaboration with Kyowa Kirin Co., Ltd. on rocatinlimab, pending regulatory approvals.